Uncemented Tritanium TKR vs Cemented Triathlon TKR
The Tritanium Uncemented Prosthesis Versus the Cemented Triathlon Prosthesis
1 other identifier
interventional
60
1 country
1
Brief Summary
The Study aims to investigate whether there is a clinically important difference in peri-articular bone mineral density (BMD) and trabecular bone score (TBS) between patients undergoing two different types of knee replacement fixation - uncemented Tritanium total knee replacement (TKR) and cemented Triathlon TKR. Before undertaking a full randomised control trial however, it is necessary to establish that the proposed methodology and approach are feasible. Therefore an internal pilot study will be performed first. This registration is for the internal pilot study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable knee-osteoarthritis
Started Oct 2019
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2019
CompletedFirst Posted
Study publicly available on registry
August 1, 2019
CompletedStudy Start
First participant enrolled
October 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedFebruary 12, 2025
February 1, 2025
6.1 years
July 12, 2019
February 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment and comparison of Trabecular Bone Score (TBS) between patients undergoing two different types of knee replacement fixation - uncemented Tritanium knee replacement and cemented Triathlon knee replacement.
We plan to compareTBS data between patients randomised to the 2 arms of the trial: the uncemented Tritanium and cemented Triathlon total knee replacement. TBS is a texture parameter that evaluates gray-level pixel-by-pixel variations and provides an assessment of fracture risk. TBS is calculated from patients DEXA scan results and is in a numerical format. Baseline TBS scores will be calculated from pre-operative DEXA scans and will be compared to post op scores. Any differences in TBS scores will be compared between participants in the 2 arms of the trial.
Our primary outcome is TBS scores at 12 months post total knee replacement
Secondary Outcomes (6)
Assessment and comparison of Trabecular Bone Score (TBS) between patients undergoing two different types of knee replacement fixation - Uncemented Tritanium knee replacement and cemented Triathlon knee replacement.
6 weeks and 6 months post-op.
Oxford Knee Score: Patient reported outcome measure (PROM)
Pre-operatively, 6 weeks post op, 6 and 12 months post op.
The Forgotten Joint Score (FJS): Patient reported outcome measure (PROM)
Pre-operatively, 6 weeks post op, 6 and 12 months post op.
The Knee Injury and Osteoarthritis Outcome Score (KOOS): Patient reported outcome measure (PROM)
Pre-operatively, 6 weeks post op, 6 and 12 months post op.
EQ5D: Patient reported outcome measure (PROM)
Pre-operatively, 6 weeks post op, 6 and 12 months post op.
- +1 more secondary outcomes
Study Arms (2)
Uncemented Tritanium Knee Replacement
EXPERIMENTAL30 participants will be randomly allocated to receive an uncemented Tritanium total knee replacement.
Cemented Triathlon Knee Replacement
ACTIVE COMPARATOR30 participants will be randomly allocated to receive standard Triathlon cemented total knee replacements.
Interventions
This will be an internal pilot study in which patients will be blinded and randomly assigned to 1 of 2 arms with 30 patients in each arm. The first arm will receive a Triathlon knee replacement device which is cemented into place. The second arm will receive an uncemented Triathlon Tritanium TKR.
Eligibility Criteria
You may qualify if:
- Patients undergoing primary TKR at the RD+E Hospital
- Patients must have completed a consent form for the study
- Patients must be prepared to comply with the pre and post-operative investigations, attendance schedule and questionnaire schedule of the study
- If the knee for surgery is suitable for standard condylar TKR components
- The diagnosis is of tricompartmental osteoarthritis of the knee
- Aged 50-70 years at time of surgery
You may not qualify if:
- Refusal to consent to the study
- If the knee for surgery is not suitable for standard condylar TKR.
- Pregnancy
- Prisoners
- A patient known to have substance abuse or psychological disorders that could interfere with their ability to comply with the assessment schedules
- Patients unable to read or understand the patient information leaflet and consent form
- Patients who have a Body Mass Index (BMI) ≥ 38
- Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation
- Patient has received any orthopaedic surgical intervention to the lower extremities within the past year or is expected to require any orthopaedic surgical intervention to the lower extremities, other than the TKR to be enrolled in this study, within the next year
- Patient requires bilateral total knee replacements, or has a history of unsuccessful contralateral partial or total knee replacement
- Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device
- Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's disease) leading to progressive bone deterioration
- Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days)
- Patients currently taking bisphosphonate medication or have taken within the previous 10 years
- The presence of peri-articular cysts evident on the pre-operative x-ray such as could compromise the stability at the bone implant interface if the uncemented component is used
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royal Devon and Exeter NHS Foundation Trustlead
- University of Exetercollaborator
Study Sites (1)
Royal Devon and Exeter NHS Foundation Trust Hospital
Exeter, Devon, EX2 5DW, United Kingdom
Related Publications (6)
Fricka KB, Sritulanondha S, McAsey CJ. To Cement or Not? Two-Year Results of a Prospective, Randomized Study Comparing Cemented Vs. Cementless Total Knee Arthroplasty (TKA). J Arthroplasty. 2015 Sep;30(9 Suppl):55-8. doi: 10.1016/j.arth.2015.04.049. Epub 2015 Jun 3.
PMID: 26118567BACKGROUNDGundry M, Hopkins S, Knapp K. A Review on Bone Mineral Density Loss in Total Knee Replacements Leading to Increased Fracture Risk. Clin Rev Bone Miner Metab. 2017;15(4):162-174. doi: 10.1007/s12018-017-9238-4. Epub 2017 Oct 27.
PMID: 29213219BACKGROUNDMinoda Y, Kobayashi A, Ikebuchi M, Iwaki H, Inori F, Nakamura H. Porous tantalum tibial component prevents periprosthetic loss of bone mineral density after total knee arthroplasty for five years-a matched cohort study. J Arthroplasty. 2013 Dec;28(10):1760-4. doi: 10.1016/j.arth.2013.03.031. Epub 2013 Apr 30.
PMID: 23642446BACKGROUNDWinther N, Jensen C, Petersen M, Lind T, Schroder H, Petersen M. Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A prospective randomized study. Int Orthop. 2016 Feb;40(2):285-94. doi: 10.1007/s00264-015-2852-1. Epub 2015 Jul 17.
PMID: 26183139BACKGROUNDAbu-Rajab RB, Watson WS, Walker B, Roberts J, Gallacher SJ, Meek RM. Peri-prosthetic bone mineral density after total knee arthroplasty. Cemented versus cementless fixation. J Bone Joint Surg Br. 2006 May;88(5):606-13. doi: 10.1302/0301-620X.88B5.16893.
PMID: 16645105BACKGROUNDNam D, Kopinski JE, Meyer Z, Rames RD, Nunley RM, Barrack RL. Perioperative and Early Postoperative Comparison of a Modern Cemented and Cementless Total Knee Arthroplasty of the Same Design. J Arthroplasty. 2017 Jul;32(7):2151-2155. doi: 10.1016/j.arth.2017.01.051. Epub 2017 Feb 7.
PMID: 28238584BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ben Waterson, MD
Royal Devon and Exeter NHS Foundation Trust Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The following people will be blinded as to which arm of the study the patient is allocated to: * The patient * The statistician who performs the analysis of the results * The radiographer reporting upon the DXA scan results
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2019
First Posted
August 1, 2019
Study Start
October 15, 2019
Primary Completion
December 1, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
February 12, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
As this is an internal pilot study it is hoped that the data collected from this trial confirms that the methodology and approach are feasible and allows us to progress to a larger randomised control trial.